Influence of demographic profile and symptoms on insight among people with schizophrenia
DOI:
https://doi.org/10.29120/ijpsw.2020.v11.i1.215Abstract
Introduction: Insight facilitation is an integral step to achieve good treatment outcome in schizophrenia. Low insight always leads to poor drug adherence and treatment resistance. The study aimed to examine how demographic profile and symptoms influencing the insight among people with schizophrenia. Methods and Materials: Objectives were to assess socio-demographic variables, the symptoms, and insight among people with Schizophrenia and to understand the influence of those variables on the insight. The descriptive research design opted for the study. Sample size of the quantitative study was 53, and subjects were selected as per the study inclusion and exclusion criteria. The population of the study was patients who were attending the outpatient department of psychiatry at the National Institute of Mental Health and Neuro Sciences (NIMHANS). Results: Age and age at the onset of illness were not associated with insight. Male participants had better insight compared to female participants. Persons with middle school or primary school education reported better insight than illiterate, graduates or professional graduates. Participants from the urban area had better insight than participants from the rural area. Insight and positive and negative symptoms were negatively correlated. Conclusion: The demographic factors and symptoms influence the insight among people with Schizophrenia. Hence such factors must be considered while insight facilitation for increasing the adherence to the treatment.
Keywords: Insight, schizophrenia, positive, negatives symptoms
References
Joseph B, Muralidhar D, Varambally S, Kumar, DA. Systematic narrative synthesis of psychosocial interventions to enhance insight in schizophrenia. Asian J Psychiatr 2017;25(1):60-76.
Dam J. Insight in schizophrenia: a review. Nord Psykiatr Tidsskr 2006;60(2):114-20.
Lincoln TM, Lüllmann E, Rief W. Correlates and long-term consequences of poor insight in patients with schizophrenia. A systematic review. Schizophr Bull 2007;33(6):1324-42.
Mohamed S, Rosenheck R, McEvoy J, Swartz M, Stroup S, Lieberman JA. Cross-sectional and longitudinal relationships between insight and attitudes toward medication and clinical outcomes in chronic schizophrenia. Schizophr Bull 2008;35(2):336-46.
Cañas F, Alptekin K, Azorin JM, Dubois V, Emsley R, García et al. Improving treatment adherence in your patients with schizophrenia. Clin Drug Investig, 2013; 33(2):97-107.
Saeedi H, Addington J, Addington D. The association of insight with psychotic symptoms, depression, and cognition in early psychosis: a 3-year follow-up. Schizophr Res 2007; 89(1):123-8.
Nakano H, Terao T, Iwata N, Hasako R, Nakamura J. Symptomatological and cognitive predictors of insight in chronic schizophrenia. Psychiatry Res 2004;127(1):65-72.
Amador XF, Gorman JM. Psychopathologic domains and insight in schizophrenia. Psychiatr Clin North Am1998;21(1):27-42.
Amador XF, Strauss DH, Yale SA, Gorman JM. Awareness of illness in schizophrenia. Schizophr Bull 1991;17(1):113-132.
Stefanopoulou E, Lafuente AR, Fonseca JAS, Huxley A.Insight, global functioning and psychopathology amongst in-patient clients with schizophrenia. Psychiatry Q2009;80(3):155-65.
Cuesta MJ, Peralta V, Campos MS, Garcia-Jalon E. Can insight be predicted in first-episode psychosis patients? A longitudinal and hierarchical analysis of predictors in a drug-naïve sample. Schizophr Res 2011;130(1):148-56.
Campos MS, Garcia-Jalon E, Gilleen JK., David AS, Peralta MDV, Cuesta MJ. Premorbid personality and insight in first-episode psychosis. Schizophr Bull 2010;37(1):52-60.
Pousa E, Ochoa S, Cobo J, Nieto L, Usall J, Gonzalez B et al. A deeper view of insight in schizophrenia: Insight dimensions, unawareness and misattribution of particular symptoms and its relation with psychopathological factors. Schizophr Res 2017:61-8
Hélène T, Hélène V, Jean B, Jean-Marc D, Antoinette P. Impact of interpersonal factors on insight in schizophrenia. Schizophr Res 2014;159(2):527-32.
Konstantakopoulos G, Ploumpidis D, Oulis P, Patrikelis P, Nikitopoulou S, Papadimitriou GN, David AS. The relationship between insight and theory of mind in schizophrenia. Schizophr Res 2014;152(1):217-22.
Mohamed S, Rosenheck R, He H, Yuping N. Insight and attitudes towards medication among inpatients with chronic schizophrenia in the US and China. Soc Psychiatry Psychiatr Epidemiol 2014;49(7):1063-70.
Konstantakopoulos G, Ploumpidis D, Oulis P, Patrikelis P, Nikitopoulou S, Papadimitriou GN et al. The relationship between insight and theory of mind in schizophrenia. Schizophr Res 2014;152(1): 217-22.
Eticha T, Teklu A, Ali D, Solomon G, Alemayehu A. Factors associated with medication adherence among patients with schizophrenia in Mekelle, Northern Ethiopia. PLoSOne2015;10(3):e0120560
Belvederi Murri M, Amore M, Calcagno P, Respino M, Marozzi V, Masotti M et al. The “insight paradox” in schizophrenia: magnitude, moderators and mediators of the association between insight and depression. Schizophr Bull 2016;42(5):1225-33.
Beck EM, Cavelti M, Kvrgic S, Kleim B, Vauth R. Are we addressing the ‘right stuff’ to enhance adherence in schizophrenia? Understanding the role of insight and attitudes towards medication. Schizophr Res 2011;132(1):42-9.
Sharma R. Kuppuswamy’s Socioeconomic Status Scale–revision for 2011 and formula for real-time updating. Indian J Pediatr 2012;79(7):961-2.
Sanz M, Constable G, Lopez-Ibor I, Kemp R, David A. A comparative study of insight scales and their relationship to psychopathological and clinical variables. Psychol Med 1998;28:437-46.
David A, Buchanan A, Reed A, Almeida O. The assessment of insight in psychosis.Br J Psychiatry 1992;161(5):599-602.
Andreasen NC, Flaum M, Swayze VW, Tyrrell G, Arndt S. Positive and negative symptoms in schizophrenia: A critical reappraisal. Arch Gen Psychiatry 1990;47(7): 615-21.
Pedersen CB, Mortensen PB. Family history, place and season of birth as risk factors for schizophrenia in Denmark: a replication and reanalysis. Br J Psychiatry 2001;179(1):46-52.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2021 Manem Atchyuta Rao, Sojan Antony, Boban Joseph
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
